Dr. Martens plc (LON:DOCS)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 702.20M |
| Revenue (ttm) | 787.60M |
| Net Income (ttm) | 4.50M |
| Shares Out | 965.23M |
| EPS (ttm) | 0.00 |
| PE Ratio | 155.58 |
| Forward PE | 17.02 |
| Dividend | 0.03 (3.42%) |
| Ex-Dividend Date | Aug 28, 2025 |
| Volume | 938,953 |
| Average Volume | 2,078,582 |
| Open | 73.00 |
| Previous Close | 74.55 |
| Day's Range | 71.62 - 74.25 |
| 52-Week Range | 43.02 - 83.30 |
| Beta | 0.15 |
| RSI | 58.24 |
| Earnings Date | Jun 5, 2025 |
About Dr. Martens
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom. [Read more]
Financial Performance
In 2024, Dr. Martens's revenue was 787.60 million, a decrease of -10.20% compared to the previous year's 877.10 million. Earnings were 4.50 million, a decrease of -93.50%.
Financial StatementsNews
Dr. Martens: Iconic Brand At A Potential Bargain
Dr. Martens remains profitable despite recent challenges, with a strong brand moat and loyal customer base supporting its long-term investment case. Cost-cutting, improved inventory control, and a con...
Broker Tips: Dr Martens, Aberdeen, Greatland Gold
Broker tips for UK stocks that have caught our eye this week include Dr Martens, Aberdeen and Greatland Gold
New Dr Martens boss plans revival by focusing on shoes and sandals as well as boots
Ije Nwokorie (pictured), who took over this year, said the 'narrow focus on boots failed to take full advantage' of other areas of the business.
Dr. Martens plc Non-GAAP EPS of 2.40p, revenue of £787.6M
Dr. Martens plc 2025 Q4 - Results - Earnings Call Presentation
Dr. Martens plc (DOCMF) Q4 2025 Earnings Conference Call Transcript
Dr Martens sees profits slide but on track for return to growth
The footwear group reported pre-tax profits of £8.8 million for the year to March 30, down from £93 million the previous year.
Dr Martens forecasts return to profit growth, shares jump
British bootmaker Dr Martens forecast a return to profit growth in the current financial year on Thursday, backed by its new CEO's plan to put more emphasis on shoes, sandals, and bags, as well as the...
FTSE 100 Live 05 June: Dr Martens results, index flat ahead of ECB rate cut
Botched expansion puts the boot into Dr Martens
The FTSE 250 firm is predicted to report a pre-tax profit of £28 million for the year to March 31, 2025, 69 per cent down on a year ago.
Companies Reporting: Pennon, BAT, B&M, Fevertree, Dr Martens
Pennon, BAT, B&M, Fevertree, Dr Martens are amongst the FTSE 350 and other companies reporting earnings for the week of 02 June
Dr. Martens Selects Amperity to Transform Customer Data Strategy
LONDON--(BUSINESS WIRE)-- #AdTech--Amperity, an AI-powered customer data cloud, today announced Dr. Martens, an iconic British brand, has selected its platform to support its global data and marketing...
Dr. Martens plc (DOCMF) Q3 2025 Sales/ Trading Statement Call Transcript
UK Stock Market News: Johnson Matthey, Dr Martens, Ryanair
Can Johnson Matthey placate activist investors? Q3 numbers show Dr Martens remains big in Japan, Ryanair update shows strong Christmas
FTSE 100 Live 27 January: Ryanair and Dr Martens post updates, index seen lower
'Welsh, fat and working-class is my superpower'
Over the past few years Megan Winstone has taken photographs for Vogue, Kerrang! and Dr. Martens.
Half Year 2025 Dr Martens PLC Earnings Call Transcript
Half Year 2025 Dr Martens PLC Earnings Call Transcript
Dr Martens boosted by good start to Christmas trading
Departing chief says bootmaker has started to stabilise after several profit warnings and poor performance in the US
Dr Martens’ shares jump 15% on new CEO’s start date despite drop in first half sales
Dr Martens said its new CEO Ije Nwokorie will take over from incumbent Kenny Wilson on Jan. 6 2025, in a shakeup investors hope could boost the struggling boot maker
Dr Martens Surges as Sales Rise and US Shows Signs of Recovery
Dr Martens Plc shares soared after the footwear company reported a better-than-expected interim performance and said it’s on track to meet targets unveiled earlier this year.
Dr Martens swings to loss and braces for currency hit
The bootmaker reported pre-tax losses of £28.7 million for the six months to September 29 against profits of £25.8 million the previous year.
Three Quick Facts: Direct Line, Loungers, Dr Martens
Aviva’s approach for Direct Line confirmed – and rejected, Loungers set to fold to private equity bid, headwinds persist at Dr Martens
Dr Martens sees strong US holiday sales, cuts inventory and debt
Dr Martens said on Thursday that the autumn-winter festive season had got off to an encouraging start and investors welcomed a reduction in net debt as the bootmaker tries to turn its performance arou...
FTSE 100 Live 28 November: Dr Martens posts results, Aviva and Direct Line shares in focus
Stock Picks From Seeking Alpha's October 2024 New Analysts
In October, 42 new analysts joined Seeking Alpha, sharing diverse investment ideas and strategies, from biotech to real estate. Highlighted strong buy recommendations include MicroStrategy, CorMedix, ...